The global Mesalamine Market is witnessing steady development as healthcare systems continue to address the growing burden of inflammatory bowel diseases, particularly ulcerative colitis. Mesalamine, also known as 5-aminosalicylic acid, is widely used as an anti-inflammatory medication for managing mild-to-moderate ulcerative colitis and maintaining remission. Increasing disease awareness,...